LOGIN
 
Share Page:
Back

Volume 15 , Issue 2
March/April 2000

Pages 175–184


Myelointegration of Titanium Implants: B Lymphopoiesis and Hemopoietic Cell Proliferation in Mouse Bone Marrow Exposed to Titanium Implants

M. Dwayne Rahal, MSc, DMD, PhD, FICD, Danielle Delorme, MSc, Per-Ingvar Brånemark, MD, PhD, Dennis G. Osmond, MB, ChB, DSc, FRSC


PMID: 10795449

Multinucleated giant cells have been observed at interfaces between bone marrow and titanium implants in mouse femurs. This raises concern that macrophage-derived factors might perturb local lymphohemopoiesis, possibly even predisposing to neoplasia in the B lymphocyte lineage. It has been found that an implant-marrow interface with associated giant cells persists for at least 1.5 years. Precursor B cells show early increases in number and proliferative activity. At later intervals, however, they do not differ significantly from controls, and there are no perturbations in spatial localization of either B lineage cells or DNA-synthesizing hemopoietic cells. The results of this investigation in mice demonstrate that, following initial marrow regeneration and fluctuating precursor B cell activity, and despite the presence of giant cells, titanium implants apparently become well-tolerated by directly apposed bone marrow cells in a lasting state of myelointegration. (INT J ORAL MAXILLOFAC IMPLANTS 2000;15:175–184) Key words: B lymphopoiesis, bone marrow, giant cells, hemopoietic microenvironment, titanium implants


Full Text PDF File | Order Article

 

 
Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.

 

© 2014 Quintessence Publishing Co, Inc JOMI Home
Current Issue
Ahead of Print
Archive
Author Guidelines
About
Accepted Manuscripts
Submission Form
Submit
Reprints
Permission
Advertising
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us
Help